Syndax Pharmaceuticals Inc (SNDX) Insider Trading

Name: Syndax Pharmaceuticals Inc (SNDX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 9, 2026): Metzger Michael A (Chief Executive Officer): Exercise/Conversion of 32,375 shares, $206.6K.

Get alerted when insiders trade SNDX

Email address

Loading company data...

Beta

Loading company details...

Beta